IL147095A - Retro-inverso peptides derived from leukemia inhibitory factor - Google Patents

Retro-inverso peptides derived from leukemia inhibitory factor

Info

Publication number
IL147095A
IL147095A IL147095A IL14709501A IL147095A IL 147095 A IL147095 A IL 147095A IL 147095 A IL147095 A IL 147095A IL 14709501 A IL14709501 A IL 14709501A IL 147095 A IL147095 A IL 147095A
Authority
IL
Israel
Prior art keywords
retro
peptides derived
inhibitory factor
leukemia inhibitory
inverso peptides
Prior art date
Application number
IL147095A
Original Assignee
Myelos Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Myelos Corp filed Critical Myelos Corp
Publication of IL147095A publication Critical patent/IL147095A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5415—Leukaemia inhibitory factor [LIF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IL147095A 1999-06-16 2001-12-13 Retro-inverso peptides derived from leukemia inhibitory factor IL147095A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13968599P 1999-06-16 1999-06-16
PCT/US2000/016760 WO2000077029A1 (en) 1999-06-16 2000-06-16 Retro-inverso peptides derived from leukemia inhibitory factor

Publications (1)

Publication Number Publication Date
IL147095A true IL147095A (en) 2010-12-30

Family

ID=22487838

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14709500A IL147095A0 (en) 1999-06-16 2000-06-16 Retro-inverso peptides derived from leukemia inhibitory factor
IL147095A IL147095A (en) 1999-06-16 2001-12-13 Retro-inverso peptides derived from leukemia inhibitory factor

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IL14709500A IL147095A0 (en) 1999-06-16 2000-06-16 Retro-inverso peptides derived from leukemia inhibitory factor

Country Status (6)

Country Link
EP (1) EP1183266A4 (en)
JP (2) JP2003502341A (en)
AU (1) AU5622700A (en)
CA (1) CA2376474A1 (en)
IL (2) IL147095A0 (en)
WO (1) WO2000077029A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571787A (en) 1993-07-30 1996-11-05 Myelos Corporation Prosaposin as a neurotrophic factor
EP1267911A4 (en) * 2000-03-03 2004-04-21 Amrad Corp Ltd A method of treatment
AU3713201A (en) * 2000-03-03 2001-09-12 Inst Medical W & E Hall A method of treatment
CA2645245A1 (en) 2006-03-31 2007-10-11 Queen's University At Kingston Compositions and methods for treating atherosclerosis
EP3298033B2 (en) 2015-05-18 2023-07-12 TCR2 Therapeutics Inc. Compositions and medical uses for tcr reprogramming using fusion proteins
AU2017363311A1 (en) 2016-11-22 2019-06-13 TCR2 Therapeutics Inc. Compositions and methods for TCR reprogramming using fusion proteins

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843892A (en) * 1989-12-18 1998-12-01 California Institute Of Technology Stimulation of nerve growth and/or vitality
US5700909A (en) * 1993-07-30 1997-12-23 The Regents Of The University Of California Prosaposin and cytokine-derived peptides
US6271196B1 (en) * 1996-03-05 2001-08-07 Regents Of The University Of Ca Methods of alleviating neuropathic pain using prosaposin-derived peptides
WO1998039357A1 (en) * 1997-03-05 1998-09-11 The Regents Of The University Of California Method of alleviating neuropathic pain
US6458357B1 (en) * 1997-09-09 2002-10-01 Myelos Corporation Retro-inverso neurotrophic and analgesic peptides

Also Published As

Publication number Publication date
JP2003502341A (en) 2003-01-21
AU5622700A (en) 2001-01-02
EP1183266A1 (en) 2002-03-06
EP1183266A4 (en) 2002-10-23
IL147095A0 (en) 2002-08-14
WO2000077029A1 (en) 2000-12-21
CA2376474A1 (en) 2000-12-21
JP2011144184A (en) 2011-07-28

Similar Documents

Publication Publication Date Title
PL344341A1 (en) Peptides
GB0014870D0 (en) Peptides
EP0964868A4 (en) Isolated peptides derived from mage-2
GB0128994D0 (en) Peptides
EP1173467A4 (en) Chemokine-derived synthetic peptides
GB9929464D0 (en) Complementary peptide ligande generated from the human genome
AU2002252801A1 (en) Peptides derived from colostrinin
EP1534308A4 (en) Peptides with growth inhibitory action
GB0100196D0 (en) Peptides
IL147095A0 (en) Retro-inverso peptides derived from leukemia inhibitory factor
HK1042307A1 (en) Peptide having preptin functionality
IL150458A0 (en) Novel haptotactic peptides
AU2973100A (en) Novel agouti and agouti-related peptide analogs
EP1159288A4 (en) Alpha-conotoxin peptides
IL147093A0 (en) Retro-inverso peptides derived from interleukin-3
IL147094A0 (en) Retro-inverso peptides derived from interleukin-6
IL144376A0 (en) Peptides
GB9908920D0 (en) Peptide
EP1245955A4 (en) Cytokine-like peptide
GB0121499D0 (en) Homing peptides
IL149355A0 (en) Polypeptide corporation
GB9907911D0 (en) Peptides
GB9918593D0 (en) Novel peptides
GB9918595D0 (en) Novel peptides
GB9918604D0 (en) Novel peptides

Legal Events

Date Code Title Description
MM9K Patent not in force due to non-payment of renewal fees